tamiflu japan results released, page-8

Another way to look at it, Inavir has been on sale for six quarters now.

Excluding the March quarter, which we'll hear about next Friday, Tamiflu's "ordinary" (ie seasonal market) sales have yet to beat Inavir sales in any of those quarters.

Just so we know again, Tamiflu ordinary sales were 7.5 billion yen in the March Quarter.

If we equal that we blitz DS' full year target.

If we beat that we blitz DS' full year target.